lobbying_filings_raw: 5dfd0530-8a0b-4713-9d2e-b86105d8a8a8
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | client_id | client_name | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | raw_json |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5dfd0530-8a0b-4713-9d2e-b86105d8a8a8 | Q3 | 5073 | DALRYMPLE & ASSOCIATES, LLC | 105002 | DISCOVERY LABORATORIES | 2011 | third_quarter | 2011-10-07T14:40:34.010000-04:00 | 20000.0 | 0 | 0 | 0 | {"url": "https://lda.senate.gov/api/v1/filings/5dfd0530-8a0b-4713-9d2e-b86105d8a8a8/", "filing_uuid": "5dfd0530-8a0b-4713-9d2e-b86105d8a8a8", "filing_type": "Q3", "filing_type_display": "3rd Quarter - Report", "filing_year": 2011, "filing_period": "third_quarter", "filing_period_display": "3rd Quarter (July 1 - Sep 30)", "filing_document_url": "https://lda.senate.gov/filings/public/filing/5dfd0530-8a0b-4713-9d2e-b86105d8a8a8/print/", "filing_document_content_type": "text/html", "income": "20000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Donald \"Dack\" Dalrymple, Principal", "dt_posted": "2011-10-07T14:40:34.010000-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "1926 N STREET NW", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "WASHINGTON", "registrant_state": "DC", "registrant_zip": "20036", "registrant": {"id": 5073, "url": "https://lda.senate.gov/api/v1/registrants/5073/", "house_registrant_id": 34019, "name": "DALRYMPLE & ASSOCIATES, LLC", "description": "Business Consulting", "address_1": "1926 N Street, NW", "address_2": "Suite 1", "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20036", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "DONALD \"DACK\" DALRYMPLE", "contact_telephone": "+1 202-833-1043", "dt_updated": "2022-04-06T16:04:33.500584-04:00"}, "client": {"id": 105002, "url": "https://lda.senate.gov/api/v1/clients/105002/", "client_id": 137, "name": "DISCOVERY LABORATORIES", "general_description": "Biodefense & Civilian Drug Development", "client_government_entity": false, "client_self_select": false, "state": "PA", "state_display": "Pennsylvania", "country": "US", "country_display": "United States of America", "ppb_state": null, "ppb_state_display": null, "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2011-01-10"}, "lobbying_activities": [{"general_issue_code": "DEF", "general_issue_code_display": "Defense", "description": "Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 46869, "prefix": "mr", "prefix_display": "MR.", "first_name": "DONALD", "nickname": "DACK", "middle_name": null, "last_name": "DALRYMPLE", "suffix": null, "suffix_display": null}, "covered_position": "Principal", "new": false}], "government_entities": [{"id": 30, "name": "Army, Dept of (Other)"}, {"id": 115, "name": "Ballistic Missile Defense Organization"}, {"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 236, "name": "Defense Threat Reduction Agency (DTRA)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 201, "name": "Homeland Security, Dept of (DHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 139, "name": "Natl Institutes of Health (NIH)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "HOM", "general_issue_code_display": "Homeland Security", "description": "Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 46869, "prefix": "mr", "prefix_display": "MR.", "first_name": "DONALD", "nickname": "DACK", "middle_name": null, "last_name": "DALRYMPLE", "suffix": null, "suffix_display": null}, "covered_position": "Principal", "new": false}], "government_entities": [{"id": 30, "name": "Army, Dept of (Other)"}, {"id": 115, "name": "Ballistic Missile Defense Organization"}, {"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 236, "name": "Defense Threat Reduction Agency (DTRA)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 201, "name": "Homeland Security, Dept of (DHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 139, "name": "Natl Institutes of Health (NIH)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 46869, "prefix": "mr", "prefix_display": "MR.", "first_name": "DONALD", "nickname": "DACK", "middle_name": null, "last_name": "DALRYMPLE", "suffix": null, "suffix_display": null}, "covered_position": "Principal", "new": false}], "government_entities": [{"id": 30, "name": "Army, Dept of (Other)"}, {"id": 115, "name": "Ballistic Missile Defense Organization"}, {"id": 134, "name": "Centers For Disease Control & Prevention (CDC)"}, {"id": 25, "name": "Defense, Dept of (DOD)"}, {"id": 236, "name": "Defense Threat Reduction Agency (DTRA)"}, {"id": 135, "name": "Food & Drug Administration (FDA)"}, {"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 201, "name": "Homeland Security, Dept of (DHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 139, "name": "Natl Institutes of Health (NIH)"}, {"id": 1, "name": "SENATE"}, {"id": 12, "name": "White House Office"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} |